Live from the NIH registry
Studies recruiting near Tucson right now
Top 25 of 482 recruiting studies, sorted by proximity — each links to its official registry page
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
Breast Cancer
N/A
Interventional 600 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Hypknowledge Nationwide Sleep Extension
Short Sleep Duration
N/A
Interventional 1,038 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Del Sol Research Management - Tucson East — Tucson, Arizona (5.4 mi)
· Sponsor: Crystalys Therapeutics
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Tucson, Arizona (5.4 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Arizona Arthritis & Rheumatology Associates — Tucson, Arizona (5.4 mi)
· Sponsor: Elevara Medicines Limited
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Banner - University Medicine Multispecialty Services Clinic — Tucson, Arizona (5.4 mi)
· Sponsor: Incyte Corporation
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
Pima Heart & Vascular — Tucson, Arizona (5.4 mi)
· Sponsor: Conformal Medical, Inc
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Aneurysm, Aneurysm, Intracranial
N/A
Interventional 183 participants sought
Carondelet St. Joseph's Hospital — Tucson, Arizona (5.4 mi)
· Sponsor: Stryker Neurovascular
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Amblyopia
Phase 3
Interventional 252 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Jaeb Center for Health Research
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Phase 3
Interventional 1,314 participants sought
The University of Arizona Cancer Center - North Campus ( Site 0073) — Tucson, Arizona (5.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
Cancer
N/A
Interventional 30 participants sought
University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12104 — Tucson, Arizona (5.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Adaptive Symptom Self-Management Immunotherapy Study
Breast Cancer, Colon Cancer
N/A
Interventional 400 participants sought
University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Feasibility of Breathwork Intervention With Older Adults After Knee Surgery
Surgical Stress Response, Stress Physiological
N/A
Interventional 32 participants sought
The University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: Canadian Cancer Trials Group
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tucson, Arizona (5.4 mi)
· Sponsor: GlaxoSmithKline
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: NRG Oncology